Orlistat vs Mounjaro: Which weight-loss treatment is right for you?

DoktorABC editorial team

Accurate, up-to-date health information written by our editorial team and reviewed by UK-registered prescribers.

How they work

Orlistat and Mounjaro act through entirely different mechanisms, which explains both their different efficacy profiles and their different side effect patterns.

Orlistat is a lipase inhibitor. It blocks the enzymes in the gut that break down dietary fat, preventing approximately one third of consumed fat from being absorbed. It has no effect on appetite, hormones, or blood sugar. Weight loss comes from the resulting reduction in caloric absorption, alongside the dietary changes the medicine encourages.

Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist. It mimics two naturally occurring gut hormones that regulate appetite, digestion, and insulin secretion. It reduces hunger and cravings by acting on the brain's appetite centres, slows gastric emptying to prolong feelings of fullness, and improves insulin sensitivity. It does not act on dietary fat directly.

Efficacy: what the evidence shows

The clinical trial evidence shows a substantial difference in average weight loss between the two medicines. Let’s look at the trial data to understand more. 

NICE TA22 data shows that patients taking orlistat alongside an appropriate diet and exercise programme lost an average of 5 to 10% of their starting body weight over 12 months, with those on orlistat losing an average of 5.8% more than those on placebo. 

The SURMOUNT-1 trial showed that participants on Mounjaro 15 mg lost an average of 20.9% of their starting body weight over 72 weeks, with those who completed the full trial on treatment achieving an average of 22.5%. 

The efficacy gap is substantial. However, it should be considered alongside the differences in mechanism, cost, side effects, and suitability. A larger average weight loss does not automatically make Mounjaro the right choice for every patient.

Side effects: What to expect from each

Because orlistat and Mounjaro work through entirely different mechanisms, their side effect profiles are also quite different. The table below sets out the key comparisons, followed by a brief explanation of each.

Orlistat's side effects are directly tied to dietary fat intake and reduce significantly with a low-fat diet. Mounjaro's GI side effects are systemic and most pronounced during the titration phase, typically improving over time.

Administration: Tablet vs injection

Orlistat is taken orally as a capsule up to three times daily with fat-containing meals. It requires consistent daily engagement with the dosing schedule and dietary planning.

Mounjaro is a once-weekly subcutaneous injection using a pre-filled pen. Most patients adapt quickly to the injection process, though it does require you to be comfortable with self-administration. The once-weekly dosing requires significantly less day-to-day management than orlistat.

For patients who are uncomfortable with injections, orlistat's oral format is a meaningful practical advantage. For those who find daily medication management difficult, Mounjaro's once-weekly dosing may suit better.

UK eligibility and prescribing

Orlistat is available on the NHS under NICE TA22 for adults with a BMI of 28 or above with associated risk factors, or 30 or above without. It is also available in a lower 60 mg dose (Alli) over the counter from pharmacies.

Mounjaro is available on the NHS through specialist tier 3/4 weight management services under NICE TA1026, with strict eligibility criteria. For most patients, it is accessed via private prescription. It is also licensed for type 2 diabetes, where it may be prescribed by a GP on the NHS.

Who each option suits

Before starting either treatment, it is important to evaluate which option is best for your personal health profile. Decisions should always be discussed with a UK-registered prescriber. 

Orlistat may suit you better if you:

• Prefer an oral medicine and are uncomfortable with injections
• Are cost-conscious and seeking an affordable first-line option
• Have a diet high in fat that you are committed to reducing
• Meet NHS eligibility criteria and can access it without private cost
• Are looking for a well-established treatment with a long safety record

Mounjaro may suit you better if you:

• Require more substantial weight loss to address cardiovascular, metabolic, or joint health concerns
• Have type 2 diabetes and would benefit from the dual glucose-lowering and weight-loss effect
• Are comfortable with weekly self-injection
• Have tried orlistat and found the results insufficient
• Can sustain the higher private prescription cost

Can you take orlistat and Mounjaro together?

There is no established formal contraindication between the two medicines, but combining them is off-label and requires individual prescriber assessment. The two act through entirely different mechanisms and there is no robust clinical evidence base either supporting or advising against the combination as a standard approach.

Final thoughts

Orlistat and Mounjaro are both legitimate, evidence-based options for weight management in the UK, suited to different patients for different reasons. Orlistat is affordable, oral, and well-established, but requires active dietary engagement and produces more modest results. Mounjaro is more potent and convenient to dose, but at a significantly higher cost and requiring weekly injection.

The right choice depends on your health profile, weight-loss goals, and individual circumstances.

FAQ

The DoktorABC medical advisory board

Dr. Roland Ruiken

Medical advisor, Norway

Dr. Viktor Simunovic

Medical advisor, Croatia

To the medical advisory board